Join this live presentation followed by a Q&A for an enlightening exploration into the resurgence of psychedelic therapy in the treatment of addiction. Delve into the latest scientific and medical breakthroughs that highlight the safety and efficacy of psychedelic interventions in addressing a spectrum of psychiatric disorders, particularly addiction.

Dr. Zafar will guide attendees through a comprehensive review of the research landscape, beginning with an examination of the socioeconomic impact of addiction and current treatment modalities. Journey back in time as historical studies from the mid-late 1900s are revisited, offering valuable insights into the initial forays into psychedelic research.

Moving forward, gain an understanding of the real-world evidence gathered from naturalistic, observational, and survey-based studies, shedding light on the tangible benefits of psychedelic therapies. Explore contemporary clinical trials, from first-in-human endeavors to phase II clinical trials, including pioneering investigations such as the groundbreaking study of psilocybin therapy in gambling disorder.

Moreover, discover innovative translational human neuropsychopharmacology techniques utilized in elucidating therapeutic mechanisms. From functional magnetic resonance imaging (fMRI) to positron emission tomography (PET), uncover the tools driving our understanding of psychedelic therapy’s intricate effects on the brain.

This event offers a unique opportunity to deepen your knowledge of psychedelic therapy’s potential in addiction treatment, ultimately paving the way for enhanced drug development and improved patient outcomes.